http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2591009-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff0940dd3e8990a779e4cabc073b356d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b0c2b8eb3453e473fcf28212cf4ab98 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-11 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6811 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6804 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6851 |
filingDate | 2018-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c6520f6dbcc958f2ee461c36071cbf2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e1823cc102541b67cf392ba6c800295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fda9daca768fdc13cd544886864a410d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3f809b33beb1ec17d48374d886081f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_125dd8a53fa74fb2eac5c98bfa6eaed7 |
publicationDate | 2021-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | GB-2591009-A |
titleOfInvention | Composite target-tumor serum nucleic acid ligand detection method and kit |
abstract | A composite target-tumor serum nucleic acid ligand detection method and a kit. The method is a method for detecting a target of a marker in a composite sample, and is a method for converting a target marker signal into a ligand nucleic acid signal by binding a nucleic acid ligand group of a specific target to a target, and performing dynamic quantitative detection by using multiplex real-time quantitative PCR. The kit comprises a magnetic bead capture reagent, a detection reagent, a blocking solution, a washing solution, and a real-time quantitative PCR reaction solution; magnetic bead capture particles having a particle diameter of 5-5000 nm are dissolved in the magnetic bead capture reagent; the blocking solution is a protein blocking solution; tumor and non-tumor serum specific nucleic acid ligand groups are dissolved in the detection reagent; the real-time quantitative PCR reaction solution comprises a primer, and a fluorescent probe for the nucleic acid ligand. The method has the characteristics of high speed, high sensitivity, strong specificity, simultaneous detection of multiple ligands. |
priorityDate | 2018-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.